Emerging Weight Loss Peptides Beyond GLP-1s The future of medical weight loss involves novel compounds that address cellular metabolism and neurotransmitter balance, providing alternatives or additions to standard incretin therapy
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
To some people, yesthough others barely feel anything at all
By combining the metabolic benefits of B12 with proven weight-loss medications, our patients achieve faster, more sustainable results while feeling strong and energized
Still others note that any change in routine, including injection stress, can produce psychosomatic headaches
If diet and exercise havent helped you lose stubborn fat, AOD-9604 may offer a solution